O'CONNOR DANIEL J. (President and CEO) reported 1 transaction at AMBRX BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/7/2024ACC: 0000950170-24-028190
DirectorOfficer· President and CEO
Since Oct 2023
-2.04M
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
5
Total transactions
2.04M disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−48.20K
Price / share
—
Trade value
—
% of position
New position
3/7/2024
48.20K→0.00
Total
Net shares
−48.20K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/7/2024 | D · Disposition | −48.20K | — | — | New position | 48.20K | 0.00 |
| Total | −48.20K | $0.00 | ||||||
Derivative Transactions4
Restricted Stock Units
Direct
Converts to
Common Stock
294.64K shares
Shares
−294.64K
Strike price
Held after
0.00
Exercisable
—
3/7/2024
Restricted Stock Units
Direct
Converts to
Common Stock
750K shares
Shares
−750K
Strike price
Held after
0.00
Exercisable
—
3/7/2024
Option to Purchase Common Stock
Direct
Converts to
Common Stock
772.86K shares
Shares
−772.86K
Strike price
0.91
Held after
0.00
Exercisable
—
3/7/2024
Option to Purchase Common Stock
Direct
Converts to
Common Stock
173.78K shares
Shares
−173.78K
Strike price
16.66
Held after
0.00
Exercisable
—
3/7/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock294.64K shares | 3/7/2024 | D · Disposition | −294.64K | — | 0.00 | |
| Restricted Stock Units Direct | Common Stock750K shares | 3/7/2024 | D · Disposition | −750K | — | 0.00 | |
| Option to Purchase Common Stock Direct | Common Stock772.86K shares | 3/7/2024 | D · Disposition | −772.86K | 0.91 | — | 0.00 |
| Option to Purchase Common Stock Direct | Common Stock173.78K shares | 3/7/2024 | D · Disposition | −173.78K | 16.66 | — | 0.00 |